Follow-up study for a device that closes an abnormal heart blood vessel
Part of Genetic & congenital, Heart & circulation clinical trials.
This study checks how well and how safely the Occlutech PDA Occluder works over time to close a patent ductus arteriosus (PDA). You may be considered if your PDA can be treated with this non-surgical device and you can return for follow-up visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a PDA defect that the device is approved to treat based on the instructions for use
- You can have the device placed through a blood vessel (your body size is not limited as long as access is possible)
- You or your parent/guardian understands the study and agrees to join
- You’re able and willing to come back for scheduled follow-up visits and checks
- You do not have major heart-lung circulation problems listed in the instructions for use (like very high pressure or very high resistance in lung blood vessels)
- No blocking blood clot, recent heart infection, blood-clotting disorder, nickel/titanium allergy, contrast dye intolerance, or too-small blood vessels for the procedure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients who had a small heart device (HeartR PDA Occluder) placed to close an opening in their heart called a PDA. Researchers will check how well the device is working and track the patient's health over time.
This follow-up study monitors how well and how safely the Occlutech mVSD device works to close certain muscular heart “holes” (ventricular septal defects). You may join if you already had the device placed and can return for scheduled checkups to help doctors learn long-term outcomes.
This trial monitors children who had a ventricular septal defect (VSD) closed with a device to see how they do over time. It checks if the closure stays effective and if there are any long-term issues.
This study keeps a national record of babies with a heart connection called a PDA who are being considered for closure using a catheter procedure. It may help doctors improve how they choose treatment and devices for babies with different health needs.
This study looks at how closing a heart valve problem (patent ductus arteriosus, or PDA) using a catheter procedure affects how your heart chambers change shape and work. Researchers want to understand if this minimally invasive procedure improves heart function.
This study looks at how well children do when their PDA is closed using a catheter (a thin tube through a blood vessel). It helps doctors understand the best ways to treat this common heart condition in kids ages 6 months to 16 years.
Hear when a new Patent Ductus Arteriosus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.